Table 3. Serum miRNA expression levels in CHC patients and healthy controls.
miRNA | CHC patients (n = 106) | Controls (n = 40) | P value |
---|---|---|---|
miR-146a | 2.75 (1.07–13.62) | 5.77 (5.14–22.75) | 0.011* |
miR-34a | 3.54 (1.71–7.3) | 0.61 (0.28–0.78) | <0.0001* |
miR-130a | 3.41 (1.73–10.7) | 1.01 (0.12–1.03) | <0.0001* |
miR-19a | 6.28 (2.29–20.12) | 1.36 (0.91–2.03) | <0.0001* |
miR-192 | 1.91 (0.82–3.6) | 0.64 (0.05–0.86) | <0.0001* |
miR-195 | 21.56 (8.75–53.1) | 9.8 (4.8–19.3) | 0.0002* |
miR-296 | 2.2 (0.89–3.82) | 0.4 (0.2–0.62) | <0.0001* |
Data are expressed as median (25%-75% percentiles) and were analyzed by Mann-Whitney U test.
* indicates statistical significance (P<0.05).